REFERENCES
- Alm A, Stjernschantz J. Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: A comparison with timolol. Ophthalmology. 1995; 102: 1743–1752
- Camras C B. United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month, masked, multicenter trial in the United States. Ophthalmology. 1996; 103: 138–147
- Watson P, Stjernschantz J. Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126–137
- Shin D H, Feldman R M, Sheu W P. Fixed Combination Latanoprost/Timolol Study Group. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. Ophthalmology. 2004; 111: 276–282
- Konstas A G, Kozobolis V P, Lallos N, Christodoulakis E, Stewart J A, Stewart W C. Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol 0.5% and dorzolamide 2%/timolol 0.5%. Eye. 2004; 18: 1264–1269
- Book S A. Essentials of Statistics. McGraw Hill, New York 1978; 117–122; 205–215
- Mundorf T K, Cate E A, Sine C S, Otero D W, Stewart J A, Stewart W C. The safety and efficacy of switching timolol 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocul Pharmacol Ther. 1998; 14: 129–135
- Duff G R. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intraocular pressure. Acta Ophthalmologica 1987; 65: 618–621
- Stewart W C, Leland T M, Cate E A, Stewart J A. Efficacy and safety of timolol solution once daily vs. timolol gel in treating elevated IOP. J Glaucoma. 1998; 7: 402–407
- Stewart W C, Sharpe E D, Harbin T S, Jr, Pastor S A, Day D G, Holmes K T, et al. Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce the intraocular pressure. Am J Ophthalmol. 2000; 129: 723–727
- Siegel S. Non Parametric Statistics. Series in Psychology. McGraw Hill, New York 1956; 63–67
- Clineschmidt C M, Williams R D, Snyder E, Adamsons I A. A randomized trial in patients inadequately controlled on timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Ophthalmology 1999; 106: 17–24
- Boyle J E, Ghosh K, Gieser D K, Adamsons I A. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol or dorzolamide. Ophthalmology. 1999; 106: 10–16
- Strohmaier K, Snyder E, Du Biner H, Adamsons I. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Ophthalmology. 1999; 106: 1–9
- Pfeiffer N. European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol. 2002; 240: 893–899
- Higginbotham E J, Feldman R, Stiles M, Dubiner H. Fixed Combination Investigative Group. Latanoprost and timolol combination therapy vs monotherapy: One-year randomized trial. Arch Ophthalmol. 2002; 120: 915–922
- Diestelhorst M, Larsson L I. European Latanoprost Fixed Combination Study Group. A 12-week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. Br J Ophthalmol. 2004; 88: 199–203
- Diestelhorst M, Larsson L I. European-Canadian Latanoprost Fixed Combination Study Group. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components. Ophthalmology. 2006; 113: 70–76
- Stewart W C, Stewart J A, Day D, Sharpe E D. Efficacy and safety of timolol/latanoprost fixed combination versus timolol and brimonidine given twice daily. Acta Ophthalmol Scand. 2003; 81: 242–246
- Konstas A G, Lake S, Economou A I, Kaltsos K, Jenkins J N, Stewart W C. 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone. Arch Ophthalmol. 2006; 124: 1553–1557
- Lippa E A, Carlson L E, Ehinger B, Eriksson L O, Finnstrom K, Holmin C, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1992; 110: 495–499